2001
DOI: 10.1089/107632701300062778
|View full text |Cite
|
Sign up to set email alerts
|

Demineralized Bone Matrix as a Biological Scaffold for Bone Repair

Abstract: Experimental models were created in rat fibula to represent impaired bone healing so that biological deficiencies that cause bone repair to fail or to be delayed may be investigated. These models consist of a 4-mm-long segmental defect, created in rat fibula by osteotomy, and fitted with a 7-mm-long tubular specimen of demineralized bone matrix (DBM) over the cut ends of the fibula. The experiments in this study involved various modifications of the DBM scaffold designed to reduce its osteoinductive activity: … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
21
0

Year Published

2007
2007
2020
2020

Publication Types

Select...
6
4

Relationship

0
10

Authors

Journals

citations
Cited by 46 publications
(21 citation statements)
references
References 30 publications
0
21
0
Order By: Relevance
“…1). The decline was more marked in the trabecular bone compared to the cortical bone (36% liquid diet for 45 days, BAC=175-190 mg/dL) [43,44].…”
Section: Microarchitecturementioning
confidence: 98%
“…1). The decline was more marked in the trabecular bone compared to the cortical bone (36% liquid diet for 45 days, BAC=175-190 mg/dL) [43,44].…”
Section: Microarchitecturementioning
confidence: 98%
“…They can be classified into natural or synthetic ceramics, natural or synthetic polymers, or composites/hybrids from these materials [38,91]. Naturally-derived ceramic materials include, in addition to autografts and allografts, bones [92,93], starch-based compounds [94], and coral derivatives [95]. Synthetic ceramics include inorganic materials, such as calcium phosphates (CaPs), bioactive glasses, and glass-ceramics [90,96].…”
Section: The Main Biomaterials Usable To Build Scaffolds/matricesmentioning
confidence: 99%
“…Many biological and biophysical interventions have been used in an attempt to accelerate fracture healing times including the use of bone graft substitutes [4,5], application of exogenous local recombinant growth factors [6,7], gene therapy [8], or tissue engineering approaches with biodegradable scaffolds [9,10]. Several modalities have gone on to be clinically useful such as recombinant growth factors, but high costs continue to preclude routine clinical use.…”
Section: Introductionmentioning
confidence: 99%